Carole Henique-Greciet

Title: Carole Henique-Greciet: Innovator in Glomerulonephritis Research

Introduction

Carole Henique-Greciet is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the area of glomerulonephritis. With a total of 3 patents to her name, her work has the potential to impact the treatment and understanding of kidney diseases.

Latest Patents

Among her latest patents is the invention titled "USE OF CD9 AS A BIOMARKER AND AS A BIOTARGET IN GLOMERULONEPHRITIS OR GLOMERULOSCLEROSIS." This patent focuses on the identification of CD9 as a crucial biomarker for these conditions. Another notable patent is "Methods for the prevention and the treatment of extracapillary glomerulonephritis." This invention addresses the prevention and treatment of extracapillary glomerulonephritis, including rapidly progressive glomerulonephritis and collapsing glomerulonephritis.

Career Highlights

Carole has worked with esteemed institutions such as Université Paris Descartes and the National Institute of Health and Medical Research. Her research has been pivotal in advancing the understanding of kidney-related diseases and their treatment options.

Collaborations

Throughout her career, Carole has collaborated with notable colleagues, including Pierre-Louis Tharaux and Martin Flamant. These partnerships have further enriched her research and contributed to her innovative work.

Conclusion

Carole Henique-Greciet stands out as a dedicated inventor in the field of glomerulonephritis research. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.